Drugs / OQL011
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04088318 | Dec 2019 → Feb 2024 | hand-foot syndrome | OnQuality Pharmaceuticals (USA) LLC | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OQL011 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04088318 ↗ |
| Route | Topical | “OQL011, Dose I, ointment, to be applied topically” NCT04088318 ↗ |